HealthInvest Partners AB
Latest statistics and disclosures from Atle Fund Management AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LLY, ABBV, NBIX, MRK, TMO, and represent 35.75% of Atle Fund Management AB's stock portfolio.
- Added to shares of these 10 stocks: KRYS, RNA, ONC, NBIX, CELC, MRK, TMO, IRON, SLNO, ABBV.
- Started 2 new stock positions in RNA, CELC.
- Reduced shares in these 9 stocks: VRNA, BSX, AMGN, VRTX, SYK, LLY, MRUS, MIRM, COR.
- Sold out of its position in VRNA.
- Atle Fund Management AB was a net seller of stock by $-3.3M.
- Atle Fund Management AB has $27M in assets under management (AUM), dropping by -88.46%.
- Central Index Key (CIK): 0001381843
Tip: Access up to 7 years of quarterly data
Positions held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 38 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 11.2 | $3.0M | -3% | 37k | 81.00 |
|
| Abbvie (ABBV) | 8.4 | $2.3M | +5% | 92k | 24.58 |
|
| Neurocrine Biosciences (NBIX) | 5.7 | $1.5M | +16% | 103k | 14.90 |
|
| Merck & Co (MRK) | 5.3 | $1.4M | +15% | 161k | 8.91 |
|
| Thermo Fisher Scientific (TMO) | 5.2 | $1.4M | +11% | 27k | 51.49 |
|
| BeiGene Sponsored Ads (ONC) | 4.1 | $1.1M | +24% | 30k | 36.17 |
|
| Bridgebio Pharma (BBIO) | 3.6 | $964k | +5% | 175k | 5.51 |
|
| AmerisourceBergen (COR) | 3.5 | $949k | -9% | 29k | 33.18 |
|
| Intuitive Surgical Com New (ISRG) | 3.5 | $936k | +6% | 20k | 47.48 |
|
| Gilead Sciences (GILD) | 3.4 | $921k | +6% | 78k | 11.78 |
|
| Boston Scientific Corporation (BSX) | 3.3 | $898k | -31% | 87k | 10.36 |
|
| Stryker Corporation (SYK) | 3.3 | $894k | -17% | 23k | 39.25 |
|
| Alkermes SHS (ALKS) | 3.0 | $805k | +11% | 253k | 3.18 |
|
| Krystal Biotech (KRYS) | 2.9 | $791k | +109% | 42k | 18.74 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $739k | -26% | 18k | 41.58 |
|
| Mirum Pharmaceuticals (MIRM) | 2.7 | $729k | -12% | 94k | 7.78 |
|
| NewAmsterdam Pharma Co NV Ordinary Shares (NAMS) | 2.2 | $585k | +23% | 194k | 3.02 |
|
| Irhythm Technologies (IRTC) | 2.0 | $548k | +18% | 30k | 18.26 |
|
| Edwards Lifesciences (EW) | 2.0 | $542k | +14% | 66k | 8.26 |
|
| Cardinal Health (CAH) | 1.9 | $505k | +13% | 30k | 16.66 |
|
| UFP Technologies (UFPT) | 1.8 | $487k | +5% | 23k | 21.19 |
|
| Merus N V (MRUS) | 1.8 | $480k | -19% | 48k | 10.00 |
|
| Soleno Therapeutics (SLNO) | 1.6 | $432k | +48% | 60k | 7.18 |
|
| Revolution Medicines (RVMD) | 1.6 | $423k | +3% | 85k | 4.96 |
|
| Amgen (AMGN) | 1.5 | $414k | -42% | 14k | 29.96 |
|
| Dexcom Com New (DXCM) | 1.3 | $363k | 51k | 7.14 |
|
|
| Bicara Therapeutics (BCAX) | 1.3 | $342k | +38% | 204k | 1.68 |
|
| Disc Medicine (IRON) | 1.2 | $321k | +85% | 46k | 7.02 |
|
| UnitedHealth (UNH) | 1.1 | $298k | 14k | 21.70 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 1.0 | $269k | +6% | 92k | 2.93 |
|
| Avidity Biosciences Ord (RNA) | 0.9 | $240k | NEW | 52k | 4.63 |
|
| Corbus Pharmaceuticals Hldgs (CRBP) | 0.9 | $236k | 176k | 1.34 |
|
|
| Arcellx Common Stock (ACLX) | 0.8 | $224k | 26k | 8.72 |
|
|
| Summit Therapeutics (SMMT) | 0.8 | $203k | 93k | 2.19 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.8 | $202k | +5% | 1.2M | 0.17 |
|
| Celcuity (CELC) | 0.7 | $195k | NEW | 37k | 5.24 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $167k | 765k | 0.22 |
|
|
| Janux Therapeutics (JANX) | 0.5 | $129k | 50k | 2.59 |
|
Past Filings by Atle Fund Management AB
SEC 13F filings are viewable for Atle Fund Management AB going back to 2013
- Atle Fund Management AB 2025 Q3 filed Nov. 4, 2025
- Atle Fund Management AB 2025 Q2 filed July 14, 2025
- Atle Fund Management AB 2025 Q1 filed May 5, 2025
- HealthInvest Partners AB 2024 Q4 filed Feb. 4, 2025
- HealthInvest Partners AB 2024 Q3 filed Nov. 12, 2024
- HealthInvest Partners AB 2024 Q1 filed April 25, 2024
- HealthInvest Partners AB 2023 Q4 filed Jan. 30, 2024
- HealthInvest Partners AB 2022 Q4 filed Feb. 14, 2023
- HealthInvest Partners AB 2022 Q3 filed Oct. 21, 2022
- HealthInvest Partners AB 2022 Q2 filed July 8, 2022
- HealthInvest Partners AB 2022 Q1 filed May 5, 2022
- HealthInvest Partners AB 2021 Q4 filed Jan. 18, 2022
- HealthInvest Partners AB 2021 Q3 filed Nov. 8, 2021
- HealthInvest Partners AB 2021 Q2 filed Aug. 10, 2021
- HealthInvest Partners AB 2021 Q1 filed April 30, 2021
- HealthInvest Partners AB 2020 Q4 filed Feb. 5, 2021